Facing a cancer diagnosis in your beloved pet can feel overwhelming. It's a journey filled with tough decisions, emotional challenges, and the search for the best possible care. That's why we've created the "Your Pet & Cancer" guide.

This comprehensive resource is designed to empower you, the pet parent, with knowledge and options. From innovative treatments like stereotactic radiation (SRS/SRT) to understanding the evolving nature of veterinary oncology, this guide is your ally in navigating these difficult times.

Download it now to become a well-informed participant in your pet's health journey and explore the latest advancements in cancer care for pets.

Start Your Fight

Every hour matters with a cancer diagnosis — get a PetCure Oncology eGuide today by filling out the form below:

* required for response

See how we are revolutionizing cancer care through the use of Stereotactic Radiosurgery.


Stereotactic Radiosurgery (SRS) is an advanced human treatment for cancer now available to veterinary medicine.

SRS does not have the invasiveness of open surgery or the side effects of traditional radiation therapy.

In as few as one SRS treatment, most pets experience improved quality of life or even a cure.

Dr. Neal Mauldin
"After treating more than 8,000 dogs and cats with SRS, I can tell you I have seen it save lives."
Dr. Neal Mauldin
Chief Medical Officer, PetCure Oncology
Board-certified veterinarian in internal medicine, medical oncology and radiation oncology
Kelly McSwain
Kelli McSwain
Licensed Radiation Therapist for PetCure Oncology at Care Center in Cincinnati
"The entire team helped save and extend Cass's life. I'm completely convinced that PetCure Oncology is the right decision for those that want the very best treatment for their companions."
Tom Melita
Pet Parent
Scott Milligan
"When we lost our dog Juliette to cancer, it was devastating. But it was also frustrating — she could have been saved by this treatment had it been available to pets. PetCure Oncology is now our mission and our calling."
Scott Milligan
Chief Executive Officer, PetCure Oncology